rs139551528

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_004473.4(FOXE1):​c.285A>G​(p.Lys95Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00344 in 1,612,922 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0026 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0035 ( 18 hom. )

Consequence

FOXE1
NM_004473.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.205

Publications

3 publications found
Variant links:
Genes affected
FOXE1 (HGNC:3806): (forkhead box E1) This intronless gene encodes a protein that belongs to the forkhead family of transcription factors. Members of this family contain a conserved 100-amino acid DNA-binding 'forkhead' domain. The encoded protein functions as a thyroid transcription factor that plays a role in thyroid morphogenesis. Mutations in this gene are associated with the Bamforth-Lazarus syndrome, and with susceptibility to nonmedullary thyroid cancer-4. [provided by RefSeq, Nov 2016]
FOXE1 Gene-Disease associations (from GenCC):
  • Bamforth-Lazarus syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 9-97854199-A-G is Benign according to our data. Variant chr9-97854199-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 435238.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.205 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FOXE1NM_004473.4 linkc.285A>G p.Lys95Lys synonymous_variant Exon 1 of 1 ENST00000375123.5 NP_004464.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FOXE1ENST00000375123.5 linkc.285A>G p.Lys95Lys synonymous_variant Exon 1 of 1 6 NM_004473.4 ENSP00000364265.3

Frequencies

GnomAD3 genomes
AF:
0.00264
AC:
401
AN:
151694
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000677
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00256
Gnomad ASJ
AF:
0.00432
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00181
Gnomad MID
AF:
0.00641
Gnomad NFE
AF:
0.00435
Gnomad OTH
AF:
0.000960
GnomAD2 exomes
AF:
0.00267
AC:
668
AN:
250320
AF XY:
0.00263
show subpopulations
Gnomad AFR exome
AF:
0.000809
Gnomad AMR exome
AF:
0.00281
Gnomad ASJ exome
AF:
0.00269
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00148
Gnomad NFE exome
AF:
0.00412
Gnomad OTH exome
AF:
0.00524
GnomAD4 exome
AF:
0.00353
AC:
5154
AN:
1461118
Hom.:
18
Cov.:
31
AF XY:
0.00337
AC XY:
2447
AN XY:
726878
show subpopulations
African (AFR)
AF:
0.000568
AC:
19
AN:
33474
American (AMR)
AF:
0.00273
AC:
122
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.00268
AC:
70
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39660
South Asian (SAS)
AF:
0.0000928
AC:
8
AN:
86250
European-Finnish (FIN)
AF:
0.00183
AC:
97
AN:
52950
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5768
European-Non Finnish (NFE)
AF:
0.00423
AC:
4703
AN:
1111814
Other (OTH)
AF:
0.00212
AC:
128
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
290
580
870
1160
1450
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
180
360
540
720
900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00263
AC:
400
AN:
151804
Hom.:
3
Cov.:
33
AF XY:
0.00256
AC XY:
190
AN XY:
74194
show subpopulations
African (AFR)
AF:
0.000651
AC:
27
AN:
41476
American (AMR)
AF:
0.00255
AC:
39
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00432
AC:
15
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5120
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00181
AC:
19
AN:
10492
Middle Eastern (MID)
AF:
0.00685
AC:
2
AN:
292
European-Non Finnish (NFE)
AF:
0.00435
AC:
295
AN:
67846
Other (OTH)
AF:
0.000950
AC:
2
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
21
42
64
85
106
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00347
Hom.:
0
Bravo
AF:
0.00248
Asia WGS
AF:
0.000290
AC:
1
AN:
3458
EpiCase
AF:
0.00403
EpiControl
AF:
0.00356

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 27, 2017
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

FOXE1: BP4, BP7, BS2 -

not specified Benign:2
Nov 07, 2016
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Bamforth-Lazarus syndrome Benign:1
Jun 28, 2017
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
8.9
DANN
Benign
0.45
PhyloP100
-0.20
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139551528; hg19: chr9-100616481; API